Gastric Ultrasound in Term Pregnants

October 17, 2024 updated by: Feyza Calisir, Kahramanmaras Sutcu Imam University

Comparison of Gastric Volumes With Ultrasound in Diabetic and Non-diabetic Term Pregnant Women Before Elective Cesarean Section

In this study, the investigators aimed to evaluate the gastric antrum with ultrasound and compare gastric volumes in diabetic and non-diabetic pregnant women in the standard fasting state before surgery. The primary aim was qualitative assessment, while secondary objectives included quantitative assessment, comparing gastric volume, aspiration risk, and the effect of preoperative anxiety on stomach contents.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Food residues in the stomach of patients scheduled for surgery are a major risk factor for pulmonary aspiration, leading to significant morbidity and mortality. This risk is particularly critical in pregnant women who may require surgery without proper fasting. National guidelines recommend fasting for 6 hours for solid foods, 4 hours for breast milk, and 2 hours for clear liquids. These guidelines apply equally to adults and children. Pregnant patients scheduled for elective surgery follow the same fasting rules as non-pregnant patients.

Gastroparesis, defined as delayed gastric emptying without mechanical obstruction, affects 30-50% of diabetic (DM) patients. Ultrasound measurement of the gastric antral area can help identify whether the stomach is full in symptomatic patients. Gastric ultrasound is a valuable tool for assessing aspiration risk in pregnant women, especially during emergency surgeries, and has shown promise in fasting non-pregnant patients scheduled for elective surgery.

In this study, the investigators aimed to evaluate the gastric antrum using ultrasound and compare gastric volumes in diabetic and non-diabetic pregnant women in a standard fasting state before surgery. The primary goal was qualitative assessment, with secondary objectives including quantitative assessment, comparing gastric volume, aspiration risk, and the effect of preoperative anxiety on stomach contents.

Study Type

Observational

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kahramanmaraş, Turkey, 46100
        • Kahramanmaras Sutcu Imam University
      • Kahramanmaraş, Turkey, 46100
        • KahramanmarasSIU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

This cohort comprised 30 diabetic and 30 non-diabetic individuals. The included participants were mentally healthy, aged 18 and above, classified as ASA II-III according to the American Society of Anesthesiologists, and had a gestational age of 36 weeks or more.

Description

Inclusion Criteria:

  1. Patients with good mental status
  2. Pregnant patients aged ≥18 years
  3. Patients in ASA II-III group
  4. Patients complying with preoperative fasting instructions (at least 6 hours for solids, at least 2 hours for clear liquids)
  5. Term pregnant women (gestational age ≥ 36 weeks)
  6. 50-120kg weight
  7. 150cm height or taller
  8. Written informed consent

Exclusion Criteria:

  1. Taking any medication known to accelerate or delay gastric emptying, including (but not limited to) opioid-containing medications and antacids.
  2. Gastroesophageal reflux, abnormal anatomy of the upper gastrointestinal tract, previous surgical procedures for the esophagus or upper abdomen, etc. any stomach complaints
  3. Pregnant women with term labor or obstetric emergency
  4. Twin pregnancy -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
diabetic term pregnant
  1. Patients with good mental status
  2. Pregnant patients aged ≥18 years
  3. Patients in ASA II-III group
  4. Patients complying with preoperative fasting instructions (at least 6 hours for solids, at least 2 hours for clear liquids)
  5. Term pregnant women (gestational age ≥ 36 weeks)
  6. 50-120kg weight
  7. 150cm height or taller
  8. Have written informed consent
To compare gastric volumes in standard fasting state before surgery in diabetic and non-diabetic pregnant women by evaluating the gastric antrum with ultrasound.
non-diabetic term pregnant
  1. Patients with good mental status
  2. Pregnant patients aged ≥18 years
  3. Patients in ASA II-III group
  4. Patients complying with preoperative fasting instructions (at least 6 hours for solids, at least 2 hours for clear liquids)
  5. Term pregnant women (gestational age ≥ 36 weeks)
  6. 50-120kg weight
  7. 150cm height or taller
  8. Have written informed consent
To compare gastric volumes in standard fasting state before surgery in diabetic and non-diabetic pregnant women by evaluating the gastric antrum with ultrasound.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastric Antrum Quality
Time Frame: 12 months

Qualitative evaluation of the gastric antrum using ultrasound: For the qualitative evaluation of the gastric antrum, we used a grading scale where the gastric antrum is classified as Grade 0, 1, or 2. The grading criteria are as follows:

Grade 0: The stomach appears empty in both supine and right lateral decubitus positions.

Grade 1: The stomach appears empty in the supine position but shows clear fluid in the right lateral decubitus position.

Grade 2: Clear fluid is seen in the stomach in both supine and right lateral decubitus positions.

12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastric Volume
Time Frame: 12 months
Quantitative measurement of gastric volume in milliliters.
12 months
Aspiration Risk
Time Frame: 12 months
Number of participants with a high aspiration risk based on gastric volume.
12 months
Preoperative Anxiety Effect
Time Frame: 12 moths
Measurement of stomach content volume related to preoperative anxiety levels.
12 moths

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2024

Primary Completion (Actual)

July 12, 2024

Study Completion (Actual)

July 12, 2024

Study Registration Dates

First Submitted

March 22, 2024

First Submitted That Met QC Criteria

July 2, 2024

First Posted (Actual)

July 9, 2024

Study Record Updates

Last Update Posted (Actual)

October 21, 2024

Last Update Submitted That Met QC Criteria

October 17, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022/26-12

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on Gastric ultrasound

Subscribe